Results 261 to 270 of about 478,399 (303)
Some of the next articles are maybe not open access.
Chronic hepatitis B virus infection
The Lancet, 2018Chronic hepatitis B virus infection is a global public health threat that causes considerable liver-related morbidity and mortality. It is acquired at birth or later via person-to-person transmission. Vaccination effectively prevents infection and chronic hepatitis B virus carriage.
Wai-Kay, Seto +3 more
openaire +2 more sources
2018
Hepatitis B (HBV) is a viral infection of the liver and a common cause of chronic liver disease worldwide. An estimated 240 million people are affected by chronic hepatitis B (CHB) infection globally. In the United States, 850,000 to 2.2 million are estimated to be living with HBV.
Lindsay Meurer, Anthony Post
openaire +1 more source
Hepatitis B (HBV) is a viral infection of the liver and a common cause of chronic liver disease worldwide. An estimated 240 million people are affected by chronic hepatitis B (CHB) infection globally. In the United States, 850,000 to 2.2 million are estimated to be living with HBV.
Lindsay Meurer, Anthony Post
openaire +1 more source
Current Opinion in Gastroenterology, 2011
We review here new developments in chronic hepatitis B (CHB) treatment, based on review of published articles between December 2009 and November 2010.It is estimated that two-thirds of US CHB patients have not been identified, evaluated and appropriately treated, largely due to lack of knowledge and awareness of CHB among medical professionals and at ...
Hejun, Yuan, William M, Lee
openaire +2 more sources
We review here new developments in chronic hepatitis B (CHB) treatment, based on review of published articles between December 2009 and November 2010.It is estimated that two-thirds of US CHB patients have not been identified, evaluated and appropriately treated, largely due to lack of knowledge and awareness of CHB among medical professionals and at ...
Hejun, Yuan, William M, Lee
openaire +2 more sources
Management of chronic hepatitis B
Gastroenterology Clinics of North America, 2004Chronic hepatitis B (CHB) is a major worldwide cause of chronic liver disease and a significant public health issue. Three predominant clinical presentations are recognized: hepatitis B e antigen(HBeAg) or typical CHB, HBeAg-negative or atypical CHB, and inactive CHB.
Marc G, Ghany, Edward C, Doo
openaire +2 more sources
2021
Hepatitis B is a DNA virus (HBV) that causes an acute and chronic infection. The HBV is transmitted vertically from mother to child, from child to child, via sexual contacts, and through percutaneous exposure to blood or other infectious body fluids. Vaccination is fundamental in the prevention of HBV infection.
openaire +1 more source
Hepatitis B is a DNA virus (HBV) that causes an acute and chronic infection. The HBV is transmitted vertically from mother to child, from child to child, via sexual contacts, and through percutaneous exposure to blood or other infectious body fluids. Vaccination is fundamental in the prevention of HBV infection.
openaire +1 more source
Treatment of Chronic Hepatitis B
Current Pharmaceutical Design, 2002Infection with the hepatitis B virus has switched over the last 20 years from the classical HBeAg positive serologic pattern to a HBeAg negative form that is linked, in the Mediterranean basin, with the epidemiologic replacement of the causative wild-type of virus B with mutant variants, whereby mutations in the core-promoter and in the pre-core region
M, Lagget, M, Rizzetto
openaire +2 more sources
Treatment of chronic hepatitis B
The Lancet Infectious Diseases, 2001This review updates the treatment of chronic hepatitis B infection. Complete eradication of hepatitis B virus (HBV) is not possible, so the efficacy of treatment has to be assessed by whether it can limit long-term cirrhosis-related complications. We discuss two major groups of treatments--immunomodulators (interferon alfa, thymosin alpha1, therapeutic
Lai, CL, Yuen, MF
openaire +4 more sources
Pathology of Chronic Hepatitis B and Chronic Hepatitis C
Clinics in Liver Disease, 2010Histologic evaluation of the liver is a major component in the medical management and treatment algorithm of patients with chronic hepatitis B (HBV) and chronic hepatitis C (HCV). Liver biopsy in these patients remains the gold standard, and decisions on treatment are often predicated on the degree of damage and stage of fibrosis. This article outlines
openaire +2 more sources
JAMA, 2018
More than 240 million individuals worldwide are infected with chronic hepatitis B virus (HBV). Among individuals with chronic HBV infection who are untreated, 15% to 40% progress to cirrhosis, which may lead to liver failure and liver cancer.Pegylated interferon and nucleos(t)ide analogues (lamivudine, adefovir, entecavir, tenofovir disoproxil, and ...
Lydia S Y, Tang +3 more
openaire +2 more sources
More than 240 million individuals worldwide are infected with chronic hepatitis B virus (HBV). Among individuals with chronic HBV infection who are untreated, 15% to 40% progress to cirrhosis, which may lead to liver failure and liver cancer.Pegylated interferon and nucleos(t)ide analogues (lamivudine, adefovir, entecavir, tenofovir disoproxil, and ...
Lydia S Y, Tang +3 more
openaire +2 more sources
Treatment of chronic hepatitis B
Journal of Viral Hepatitis, 1994SUMMARY.Chronic infection with the hepatitis B virus (HBV) is a major cause of worldwide morbidity and mortality. A large number of therapeutic approaches has been tried, including interferon (IFN), nucleoside analogues and immunomodulators. To date controlled clinical trials have shown that only IFN is of long‐term value but many patients fail to ...
openaire +2 more sources